Company profile
Actithera
Translating medicinal chemistry insights into next-generation radioligand therapies (RLTs)
- Industry
- Biotechnology Research
- Employees
- 33
- Headquarters
- Cambridge, MA
- LinkedIn followers
- 3,462
- Office locations
- 2
Actithera company summary
Actithera is a company in the Biotechnology Research industry, headquartered in Cambridge, MA. On LinkedIn the company has around 33 employees and 3,462 followers. The company lists 2 office locations.
What technology does Actithera use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Actithera
Actithera is a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs). Founded in 2021 by drug discovery innovator Dr. Andreas Goutopoulos, and seed investors M Ventures, and Arkin Bio Ventures II, Actithera applies various molecular design strategies, including covalent-targeting and an isotope-agnostic philosophy to invent RLTs with significant differentiation and larger therapeutic windows. Headquartered in Oslo, Norway, and Cambridge, Massachusetts, Actithera is committed to advancing a differentiated pipeline addressing critical unmet needs in oncology.
Where is Actithera located?
Actithera lists 2 office locations.
Compare companies similar to Actithera
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Actithera actithera.com | Biotechnology Research | 33 | - | Cambridge, MA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Actithera
What does Actithera do?
Actithera is a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs). Founded in 2021 by drug discovery innovator Dr. Andreas Goutopoulos, and seed investors M Ventures, and Arkin Bio Ventures II, Actithera applies various molecular design strategies, including covalent-targeting and an isotope-agnostic philosophy to invent RLTs with significant differentiation and larger therapeutic windows. Headquartered in Oslo, Norway, and Cambridge, Massachusetts, Actithera is committed to advancing a differentiated pipeline addressing critical unmet needs in oncology.
How many employees does Actithera have?
Actithera has around 33 employees on LinkedIn.
Where is Actithera headquartered?
Actithera is headquartered in Cambridge, MA.
Where does Actithera have offices?
Actithera lists 2 office locations, including Cambridge, MA, US; Oslo, NO, NO.
Build a lead list from companies like Actithera
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.